MXPA04005079A - Variantes del dominio c2 del factor viii. - Google Patents
Variantes del dominio c2 del factor viii.Info
- Publication number
- MXPA04005079A MXPA04005079A MXPA04005079A MXPA04005079A MXPA04005079A MX PA04005079 A MXPA04005079 A MX PA04005079A MX PA04005079 A MXPA04005079 A MX PA04005079A MX PA04005079 A MXPA04005079 A MX PA04005079A MX PA04005079 A MXPA04005079 A MX PA04005079A
- Authority
- MX
- Mexico
- Prior art keywords
- factor viii
- domain variants
- amino acid
- loci
- inhibitory antibodies
- Prior art date
Links
- 229960000301 factor viii Drugs 0.000 title abstract 4
- 102000001690 Factor VIII Human genes 0.000 abstract 3
- 108010054218 Factor VIII Proteins 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 208000031220 Hemophilia Diseases 0.000 abstract 1
- 208000009292 Hemophilia A Diseases 0.000 abstract 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 102000057593 human F8 Human genes 0.000 abstract 1
- 229960000900 human factor viii Drugs 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33456901P | 2001-11-30 | 2001-11-30 | |
| PCT/US2002/037884 WO2003047507A2 (en) | 2001-11-30 | 2002-11-27 | Factor viii c2 domain variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04005079A true MXPA04005079A (es) | 2004-08-19 |
Family
ID=23307813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04005079A MXPA04005079A (es) | 2001-11-30 | 2002-11-27 | Variantes del dominio c2 del factor viii. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040249134A1 (enExample) |
| EP (1) | EP1456235A4 (enExample) |
| JP (1) | JP2005511038A (enExample) |
| CN (1) | CN1630666A (enExample) |
| AU (1) | AU2002364509A1 (enExample) |
| CA (1) | CA2462966A1 (enExample) |
| MX (1) | MXPA04005079A (enExample) |
| WO (1) | WO2003047507A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458563B1 (en) * | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
| US7560107B2 (en) | 1996-06-26 | 2009-07-14 | Emory University | Modified factor VIII |
| US7485291B2 (en) | 2003-06-03 | 2009-02-03 | Cell Genesys, Inc. | Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| US7709224B2 (en) | 2003-06-03 | 2010-05-04 | Biosante Pharmaceuticals, Inc. | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| US20050123997A1 (en) * | 2003-10-30 | 2005-06-09 | Lollar John S. | Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes |
| EP1750733B1 (en) * | 2004-05-03 | 2013-12-11 | Emory University | METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII |
| MY185597A (en) * | 2005-09-20 | 2021-05-24 | Avantor Performance Mat Inc | Vegetarian protein a preparation and methods thereof |
| FR2913020B1 (fr) * | 2007-02-23 | 2012-11-23 | Biomethodes | Nouveaux facteurs viii pour le traitement des hemophiles de type a |
| IT1394522B1 (it) | 2009-01-09 | 2012-07-05 | Invatec Technology Ct Gmbh | Dispositivo medicale con rilascio di farmaco |
| EP2498804A4 (en) * | 2009-11-13 | 2013-05-08 | Puget Sound Blood Ct | FACTOR VIII B CELL EPITOPARIANTS WITH REDUCED IMMUNOGENITY |
| MX2012005527A (es) | 2009-11-13 | 2012-08-08 | Grifols Therapeutics Inc | Preparaciones que contienen el factor de von willebrand (fvw) procedimientos, kits y aplicaciones relacionados con las mismas. |
| EP3466968A1 (en) * | 2010-09-15 | 2019-04-10 | Stichting Sanquin Bloedvoorziening | Factor viii variants having a decreased cellular uptake |
| US9150637B2 (en) | 2010-11-05 | 2015-10-06 | Baxalta Inc. | Variant of antihemophilic factor VIII having increased specific activity |
| WO2015127129A1 (en) * | 2014-02-19 | 2015-08-27 | Bloodworks | Factor viii b cell epitope variants having reduced immunogenicity |
| EP3114138B1 (en) | 2014-03-05 | 2021-11-17 | Pfizer Inc. | Improved muteins of clotting factor viii |
| WO2025164792A1 (ja) * | 2024-02-02 | 2025-08-07 | 学校法人自治医科大学 | 高比活性／高分泌発現型の第ｖｉｉｉ因子改変体、高発現型の第ｖｉｉｉ因子コード核酸及びそれらの用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757006A (en) * | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| JPH0788399B2 (ja) * | 1985-04-12 | 1995-09-27 | ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド | 新規プロコアギュラント蛋白質 |
| US5004803A (en) * | 1988-11-14 | 1991-04-02 | Genetics Institute, Inc. | Production of procoagulant proteins |
| US5364771A (en) * | 1992-04-07 | 1994-11-15 | Emory University | Hybrid human/porcine factor VIII |
| US6180371B1 (en) * | 1996-06-26 | 2001-01-30 | Emory University | Modified factor VIII |
| US5663060A (en) * | 1992-04-07 | 1997-09-02 | Emory University | Hybrid human/animal factor VIII |
| US5888974A (en) * | 1992-04-07 | 1999-03-30 | Emory University | Hybrid human/animal factor VIII |
| US5859204A (en) * | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
| US5744446A (en) * | 1992-04-07 | 1998-04-28 | Emory University | Hybrid human/animal factor VIII |
| US6376463B1 (en) * | 1992-04-07 | 2002-04-23 | Emory University | Modified factor VIII |
| US6458563B1 (en) * | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
| WO2002024723A1 (en) * | 2000-09-19 | 2002-03-28 | Emory University | Modified factor viii |
-
2002
- 2002-11-27 MX MXPA04005079A patent/MXPA04005079A/es not_active Application Discontinuation
- 2002-11-27 CA CA002462966A patent/CA2462966A1/en not_active Abandoned
- 2002-11-27 US US10/491,464 patent/US20040249134A1/en not_active Abandoned
- 2002-11-27 WO PCT/US2002/037884 patent/WO2003047507A2/en not_active Ceased
- 2002-11-27 JP JP2003548768A patent/JP2005511038A/ja active Pending
- 2002-11-27 CN CNA028238451A patent/CN1630666A/zh active Pending
- 2002-11-27 EP EP02799885A patent/EP1456235A4/en not_active Withdrawn
- 2002-11-27 AU AU2002364509A patent/AU2002364509A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1456235A2 (en) | 2004-09-15 |
| WO2003047507A3 (en) | 2003-07-17 |
| WO2003047507A2 (en) | 2003-06-12 |
| CN1630666A (zh) | 2005-06-22 |
| CA2462966A1 (en) | 2003-06-12 |
| EP1456235A4 (en) | 2005-08-17 |
| US20040249134A1 (en) | 2004-12-09 |
| JP2005511038A (ja) | 2005-04-28 |
| AU2002364509A1 (en) | 2003-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300808I1 (enExample) | ||
| PT1200105E (pt) | Factor viii modificado | |
| MXPA04005079A (es) | Variantes del dominio c2 del factor viii. | |
| WO2005046583A3 (en) | Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes | |
| IL189629A0 (en) | Compositions containing human ctla-4 antibodies | |
| NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| SE0200844D0 (sv) | Chemical compounds | |
| YU68602A (sh) | Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje | |
| SI1532131T1 (sl) | Motilidne spojine | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| DE602004018162D1 (de) | hERG1-KANAL-ÖFFNER ZUR BEHANDLUNG VON HERZARRYTHMIEN | |
| YU22802A (sh) | Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina | |
| DE60209886D1 (de) | Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen | |
| ATE265418T1 (de) | Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine | |
| DE60005526D1 (de) | Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |